Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Bioventus Inc shares valued at $683,736 were purchased by Bartholdson John A. on Aug 16 ’24. At $8.55 per share, Bartholdson John A. acquired 80,000 shares. The insider’s holdings grew to 6,913,857 shares worth approximately $77.71 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Bartholdson John A. purchased 25,500 shares, netting a total of over 217,966 in proceeds. Following the buying of shares at $8.55 each, the insider now holds 6,939,357 shares.
Before that, Singleton Mark Leonard had sold 9,219 shares from its account. In a trade valued at $51,350, the SVP & CFO traded Bioventus Inc shares for $5.57 each. Upon closing the transaction, the insider’s holdings decreased to 9,219 shares, worth approximately $0.95 million.
As published in a research note from Canaccord Genuity on December 07, 2023, Bioventus Inc [BVS] has been rated up from a Hold to a Buy and the price target has been revised to $7. Analysts at Craig Hallum upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early August. As of November 22, 2022, Craig Hallum has decreased its “Buy” rating to a “Hold” for BVS. Earlier on November 09, 2022, JP Morgan downgraded its rating. Their new recommendation was “an Underweight” for BVS stock which previously was a “an Overweight”.
Analyzing BVS Stock Performance
During the last five days, there has been a drop of approximately -17.17%. Over the course of the year, Bioventus Inc shares have jumped approximately 113.28%. Shares of the company reached a 52-week high of $14.38 on 11/04/24 and a 52-week low of $3.90 on 04/30/24. A 50-day SMA is recorded $11.75, while a 200-day SMA reached $7.34. Nevertheless, trading volume fell to 0.64 million shares from 1.02 million shares the previous day.
Support And Resistance Levels for Bioventus Inc (BVS)
According to the 24-hour chart, there is a support level at 10.98, which, if violated, would cause prices to drop to 10.72. In the upper region, resistance lies at 11.41. The next price resistance is at 11.59. RSI (Relative Strength Index) is 37.31 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.55, which suggests the price will decrease in the coming days. Percent R is at 44.35%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
